Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the contract from the U.
Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...
Vietnam Investment Review on MSN2d
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S.As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
The Phase I data aligns with previous preclinical findings, showing over 95% protection in non-human primates, comparable to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback